I am glad someone started this thread! Thanks
@Alrightalright
While many applications will either happen in a long time, or never due to ethical or technical issues, already there is huge research/development/trials activity. CRISPR was named the science breakthrough of the year in 2015. Large amounts were spent in the patent battle between the east and west coast US research groups. A superb book for those wanting to learn more about CRISPR is by Dr. Jennifer Doudna A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution.
I think the price has never been released, but CRISPR.com, according to GoValue comparator sales data, sold for more than $25,000 to a medical professional who also has an impressive domain portfolio. Here is an article on that.
https://www.statnews.com/2017/04/27/crispr-com-domain/
Interestingly Estibot continues to totally misinterpret the word thinking it is Crisp + r, so Estibot valuations are meaningless on this one (I know some of you will say on any word, let's not start that debate, again!).
A single large agriculture related company own a number of the other more valuable domain names and I presume they are not, or never will be, for sale. That reminds us that CRISPR applications are not only in medicine. The extensions are gone in most of the country codes and meaningful match new extensions.
Over a year ago I was able to acquire
CRISPR.science and I regard it as a great name, even though there have not yet been many significant sales in the .science extension. I have the domain renewed for another 5 years, and if it has not sold by then will definitely renew it. I have it for sale, but fear I am not asking enough for it, keep debating selling now vs holding long term. I was asking more than currently.
The big companies in gene editing (see
The Motley Fool review of three of them) already have websites of course. I suspect that the immediate market will be more for research consortiums, consultants, a few startups, etc. who will pay $$$ range but not more. I also hold the exact match CRISPR in a number of other extensions (including .review, .pw professional web, .website, .gdn global domain name, etc.) hoping for a modest sale.
While biotechnology related, I think the markets for the genetic ancestry and forensics etc. kind of domain names will be separate from the medical related applications of gene editing. I do see both being hot and in fact picked this as one of 8 hot domain name areas in my January predictions (
read here). Whether domain names incorporating DNA rather than CRISPR itself will be more likely to sell is possible, partly because people often get spelling of CRISPR wrong.
Sorry this has been so long! Yes, CRISPR will be important and already is.